$13.31
2.38% yesterday
Nasdaq, Sep 15, 10:00 pm CET
ISIN
US98978N2009
Symbol
ZIVO

Zivo Bioscience Inc Stock price

$13.31
-4.94 27.08% 1M
-4.49 25.24% 6M
-8.19 38.10% YTD
+0.31 2.37% 1Y
-7.33 35.52% 3Y
-39.49 74.80% 5Y
-33.73 71.71% 10Y
-697.09 98.13% 20Y
Nasdaq, Closing price Mon, Sep 15 2025
+0.31 2.37%
ISIN
US98978N2009
Symbol
ZIVO

Key metrics

Basic
Market capitalization
-
Enterprise Value
-
Net debt
$60.0k
Cash
$520.0k
Shares outstanding
3.8m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
-
P/B
-
Financial Health
Equity Ratio
-31.3%
Return on Equity
2,599.5%
ROCE
1,273.0%
ROIC
-
Debt/Equity
-0.4
Financials (TTM | estimate)
Revenue
$120.0k | $1.0m
EBITDA
- | $-7.2m
EBIT
$-16.3m | $-7.3m
Net Income
$-16.3m | $-6.2m
Free Cash Flow
$-4.0m
Growth (TTM | estimate)
Revenue
100.0% | 529.4%
EBITDA
- | -
EBIT
-148.3% | 45.3%
Net Income
-130.5% | 54.0%
Free Cash Flow
24.8%
Margin (TTM | estimate)
Gross
30.0%
EBITDA
- | -716.2%
EBIT
-13,411.4%
Net
-13,430.1% | -610.4%
Free Cash Flow
-3,328.9%
More
EPS
$-4.4
FCF per Share
$-1.1
Short interest
2.6%
Employees
7
Rev per Employee
$20.0k
Show more

Is Zivo Bioscience Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,016 stocks worldwide.

Zivo Bioscience Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Zivo Bioscience Inc forecast:

3x Hold
50%
3x Sell
50%

Analyst Opinions

6 Analysts have issued a Zivo Bioscience Inc forecast:

Hold
50%
Sell
50%

Financial data from Zivo Bioscience Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
0.12 0.12
100% 100%
100%
- Direct Costs 0.09 0.09
125% 125%
75%
0.04 0.04
100% 100%
33%
- Selling and Administrative Expenses 11 11
102% 102%
8,950%
- Research and Development Expense 5.59 5.59
333% 333%
4,658%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -16 -16
148% 148%
-13,579%
Net Profit -16 -16
131% 131%
-13,600%

In millions USD.

Don't miss a Thing! We will send you all news about Zivo Bioscience Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Zivo Bioscience Inc Stock News

Neutral
Business Wire
6 days ago
TROY, Mich.--(BUSINESS WIRE)--ZIVO Bioscience, Inc. (OTCQB: ZIVO), a biotech and agtech R&D company engaged in the development of therapeutic and nutritional products derived from proprietary algal cultures, today issued the following letter to shareholders from Chairman, President and Chief Executive Officer John B. Payne. Dear Fellow Shareholders, I am pleased to provide you with this importa...
Neutral
Business Wire
3 months ago
TROY, Mich.--(BUSINESS WIRE)---- $ZIVO--ZIVO Bioscience, Inc. (OTCQB: ZIVO), a biotech and agtech R&D company engaged in the development of therapeutic and nutritional products derived from proprietary algal cultures, announces it has entered into a relationship with one of the world's leading animal health companies to advance ZIVO's novel immune-boosting compounds for use in multiple poultry ...
Neutral
Business Wire
4 months ago
TROY, Mich.--(BUSINESS WIRE)--ZIVO Bioscience, Inc. (OTCQB: ZIVO), a pioneering biotech/agtech R&D company dedicated to developing therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, today announced positive results from its second collaborative study with the University of Delaware evaluating the efficacy of several formulations of ZIVO's propriet...

Company Profile

Zivo Bioscience, Inc. engages in the study, development, and commercialization of natural nutritional compounds and bioactive molecules. It offers proprietary algae strain, extracts and supernatants, and bioactive compounds. The company was founded by Howard R. Baer on March 28, 1983 and is headquartered in Keego Harbor, MI.

Head office United States
CEO John Payne
Employees 7
Founded 1983
Website zivobioscience.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today